258 related articles for article (PubMed ID: 23692737)
1. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome.
Malfait F; Symoens S; Goemans N; Gyftodimou Y; Holmberg E; López-González V; Mortier G; Nampoothiri S; Petersen MB; De Paepe A
Orphanet J Rare Dis; 2013 May; 8():78. PubMed ID: 23692737
[TBL] [Abstract][Full Text] [Related]
2. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.
Cabral WA; Makareeva E; Colige A; Letocha AD; Ty JM; Yeowell HN; Pals G; Leikin S; Marini JC
J Biol Chem; 2005 May; 280(19):19259-69. PubMed ID: 15728585
[TBL] [Abstract][Full Text] [Related]
3. COL1-related overlap disorder: A novel connective tissue disorder incorporating the osteogenesis imperfecta/Ehlers-Danlos syndrome overlap.
Morlino S; Micale L; Ritelli M; Rohrbach M; Zoppi N; Vandersteen A; Mackay S; Agolini E; Cocciadiferro D; Sasaki E; Madeo A; Ferraris A; Reardon W; Di Rocco M; Novelli A; Grammatico P; Malfait F; Mazza T; Hakim A; Giunta C; Colombi M; Castori M
Clin Genet; 2020 Mar; 97(3):396-406. PubMed ID: 31794058
[TBL] [Abstract][Full Text] [Related]
4. Osteogenesis Imperfecta/Ehlers-Danlos Overlap Syndrome and Neuroblastoma-Case Report and Review of Literature.
Morabito LA; Allegri AEM; Capra AP; Capasso M; Capra V; Garaventa A; Maghnie M; Briuglia S; Wasniewska MG
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456387
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix.
Makareeva E; Cabral WA; Marini JC; Leikin S
J Biol Chem; 2006 Mar; 281(10):6463-70. PubMed ID: 16407265
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific mosaicism for a lethal osteogenesis imperfecta COL1A1 mutation causes mild OI/EDS overlap syndrome.
Symoens S; Steyaert W; Demuynck L; De Paepe A; Diderich KE; Malfait F; Coucke PJ
Am J Med Genet A; 2017 Apr; 173(4):1047-1050. PubMed ID: 28261977
[TBL] [Abstract][Full Text] [Related]
7. Compound phenotype of osteogenesis imperfecta and Ehlers-Danlos syndrome caused by combined mutations in
Lin Z; Zeng J; Wang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239369
[TBL] [Abstract][Full Text] [Related]
8. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
[TBL] [Abstract][Full Text] [Related]
9. COL1A1 and COL1A2 variants in Ehlers-Danlos syndrome phenotypes and COL1-related overlap disorder.
Venable E; Knight DRT; Thoreson EK; Baudhuin LM
Am J Med Genet C Semin Med Genet; 2023 Jun; 193(2):147-159. PubMed ID: 36896471
[TBL] [Abstract][Full Text] [Related]
10. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
11. Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.
Cundy T; Dray M; Delahunt J; Hald JD; Langdahl B; Li C; Szybowska M; Mohammed S; Duncan EL; McInerney-Leo AM; Wheeler PG; Roschger P; Klaushofer K; Rai J; Weis M; Eyre D; Schwarze U; Byers PH
J Bone Miner Res; 2018 Jul; 33(7):1260-1271. PubMed ID: 29669177
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular features of patients with COL1-related disorders: Implications for the wider spectrum and the risk of vascular complications.
Takeda R; Yamaguchi T; Hayashi S; Sano S; Kawame H; Kanki S; Taketani T; Yoshimura H; Nakamura Y; Kosho T
Am J Med Genet A; 2022 Sep; 188(9):2560-2575. PubMed ID: 35822426
[TBL] [Abstract][Full Text] [Related]
13. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
[TBL] [Abstract][Full Text] [Related]
14. Defective Proteolytic Processing of Fibrillar Procollagens and Prodecorin Due to Biallelic BMP1 Mutations Results in a Severe, Progressive Form of Osteogenesis Imperfecta.
Syx D; Guillemyn B; Symoens S; Sousa AB; Medeira A; Whiteford M; Hermanns-Lê T; Coucke PJ; De Paepe A; Malfait F
J Bone Miner Res; 2015 Aug; 30(8):1445-56. PubMed ID: 25656619
[TBL] [Abstract][Full Text] [Related]
15. The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.
Carr AJ; Chiodo AA; Hilton JM; Chow CW; Hockey A; Cole WG
J Med Genet; 1994 Apr; 31(4):306-11. PubMed ID: 8071956
[TBL] [Abstract][Full Text] [Related]
16. Met>Val substitution in a highly conserved region of the pro-alpha1(I) collagen C-propeptide domain causes alternative splicing and a mild EDS/OI phenotype.
Symoens S; Nuytinck L; Legius E; Malfait F; Coucke PJ; De Paepe A
J Med Genet; 2004 Jul; 41(7):e96. PubMed ID: 15235039
[No Abstract] [Full Text] [Related]
17. An overlapping phenotype of Osteogenesis imperfecta and Ehlers-Danlos syndrome due to a heterozygous mutation in COL1A1 and biallelic missense variants in TNXB identified by whole exome sequencing.
Mackenroth L; Fischer-Zirnsak B; Egerer J; Hecht J; Kallinich T; Stenzel W; Spors B; von Moers A; Mundlos S; Kornak U; Gerhold K; Horn D
Am J Med Genet A; 2016 Apr; 170A(4):1080-5. PubMed ID: 26799614
[TBL] [Abstract][Full Text] [Related]
18. Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro(alpha)2(I) chain and an EDS/OI clinical phenotype.
Nicholls AC; Valler D; Wallis S; Pope FM
J Med Genet; 2001 Feb; 38(2):132-6. PubMed ID: 11288717
[No Abstract] [Full Text] [Related]
19. A novel mutation in
Budsamongkol T; Intarak N; Theerapanon T; Yodsanga S; Porntaveetus T; Shotelersuk V
Genes Dis; 2019 Jun; 6(2):138-146. PubMed ID: 31193991
[TBL] [Abstract][Full Text] [Related]
20. Delineation of Ehlers-Danlos syndrome phenotype due to the c.934C>T, p.(Arg312Cys) mutation in COL1A1: Report on a three-generation family without cardiovascular events, and literature review.
Colombi M; Dordoni C; Venturini M; Zanca A; Calzavara-Pinton P; Ritelli M
Am J Med Genet A; 2017 Feb; 173(2):524-530. PubMed ID: 28102596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
